ADRXNASDAQHealthcare
ADARX PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$17.00
-4.76%
Alpha Vantage · 10/30/2026
Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze ADRX free One-year price history
Adjusted daily closes · 26 observations · as of Oct 30, 2026
1 month
-13.0%
3 months
—
6 months
—
1 year
-12.1%
Year to date
-12.1%
52-week range
$17.00 – $20.64
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.74B
P/E
-23.8
P/B
-6.9
P/S
503.7
Revenue
—
Net income
—
Diluted EPS
—
Gross margin
—
Net margin
—
Return on equity
—
Total debt
$6.9M
Cash
$58.48M
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ADRX news
All market newsNo ticker-linked stories are in the current archive.